Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution
- Recalling company
- Wells Pharma of Houston LLC
- Product
- fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
- Reason
- cGMP deviations.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 1, 2026
- Reported
- May 6, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 50 syringes
- Lot / codes
- Lot 011226204250063, Exp Date 05/14/2026
- Company location
- Houston, TX
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0505-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0505-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.